INT149845

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.16
First Reported 2008
Last Reported 2008
Negated 0
Speculated 0
Reported most in Abstract
Documents 1
Total Number 1
Disease Relevance 0.45
Pain Relevance 1.24

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

extracellular space (Cxcl12) extracellular region (C19orf10) plasma membrane (Cxcl12)
Cxcl12 (Rattus norvegicus)
C19orf10 (Homo sapiens)
Pain Link Frequency Relevance Heat
antinociception 4 99.00 Very High Very High Very High
Antinociceptive 1 98.28 Very High Very High Very High
antagonist 3 95.16 Very High Very High Very High
Central grey 5 83.36 Quite High
chemokine 6 78.32 Quite High
Cannabinoid 3 77.20 Quite High
Analgesic 4 69.88 Quite High
Pain 3 67.64 Quite High
agonist 1 57.04 Quite High
Cannabinoid receptor 1 56.72 Quite High
Disease Link Frequency Relevance Heat
Age-related Macular Degeneration 1 96.16 Very High Very High Very High
Urological Neuroanatomy 5 83.36 Quite High
Pain 1 67.64 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
The inhibitory effect of SDF-1alpha/CXCL12 on WIN 55,212-2-induced antinociception was reversed by octahydrochloride [corrected] hydrate (AMD 3100) (10-50 ng), an antagonist of the SDF-1alpha/CXCL12, acting at its receptor, CXCR4.
CXCL12 Negative_regulation (effect) of SDF associated with antinociception, antagonist and age-related macular degeneration
1) Confidence 0.16 Published 2008 Journal J. Pharmacol. Exp. Ther. Section Abstract Doc Link 18281594 Disease Relevance 0.45 Pain Relevance 1.24

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox